Juntendo University · Graduate School of Medicine / Faculty of Medicine

Research keywordshematologic malignancies・CAR-T therapy・persistent COVID-19・B-cell malignancies・myeloproliferative neoplasms・bispecific antibodies・cell therapy

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Yasuda H, Ando J, Ando M: Persistent COVID-19 in Patients With Hematological Malignancies: A Focused Review in the Omicron Era. Clin Lymphoma Myeloma Leuk. 2026; 26: e385-e396.2026
• Yasuda H, Harada S, Matsushita M, Kinoshita S, Nomura K, Ito K, Shibuya T, Abe Y, Sakuma S, Ando M: Azathioprine withdrawal leading to spontaneous remission of Iatrogenic Epstein-Barr virus-negative diffuse large B-cell lymphoma: A case report and literature review. Intern Med. 2026 Apr 21. doi: 10.2169/internalmedicine.6968-25. Online ahead of print.2026
• Izumi N, Furukawa Y, Kinoshita S, Ishii M, Goto A, Yasuda H, Ando J, Nakauchi H, Ando M: Dual-antigen recognition iPSC-derived CAR-T cells for B-cell malignancies: establishment of a COVID-19 vaccine synergy strategy. Front Cell Dev Biol. 2026; 14: 1772146.2026
• Edahiro Y, Shirane S, Takeda J, Yasuda H, Inano T, Tsutsui M, Hamano Y, Sasaki M, Ando J, Itakura A, Ando M, Komatsu N: Assessment and management of pregnancy in patients with myeloproliferative neoplasms: insights from a single-institution study of 29 neonates. Int J Hematol. 2025; 121: 281-283.2025

• Official profile